Skip to main content
. 2016 Feb 20;8(2):25. doi: 10.3390/cancers8020025

Figure 2.

Figure 2

Figure 2

(A) Proliferating activities estimated by the MCM2-positive rate of cancer cells in Groups 1 through 4. Insert: MCM2 immunohistochemistry of adenocarcinoma developed in a mouse belonging to Group 1; (B) Apoptosis estimated by the caspase 3-positive rate of cancer cells in Groups 1 through 4. Insert: Caspase 3 immunohistochemistry of adenocarcinoma developed in a mouse belonging to Group 1.